19 May 2013
Keywords: pravastatin, action, crp, class, effect, new, study
Article | 17 April 2001
A new study has found that three of the top-selling HMG-CoA reductaseinhibitors or statins, Bristol-Myers Squibb's Pravachol (pravastatin),
Merck & Co's ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 April 2001
18 April 2001
17 May 2013
© 2013 thepharmaletter.com